Kestrel KG 深 滬
已收盤 07-02 16:00:00 美东时间
10.16
+0.680
+7.17%
華盛通- 最 高10.98
- 今 開9.63
- 成交量 2.67万股
- 最 低 9.51
- 昨 收 9.48
- 總市值 7949.21万
- 52周最高 31.61
- 市盈率 靜 1.25
- 換手率 0.34%
- 52周最低 8.07
- 委 比 80.12%
- 總股本 782.40万
- 歷史最高 36.80
- 量 比 0.35
- 振 幅 15.51%
- 歷史最低 8.07
- 每 手 1
- 風險率 7.16%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kestrel Group Shareholders Endorse Governance and Pay Policies
The latest update is out from Kestrel Group ( ($KG) ). At Kestrel Group Ltd.’s ...
06-16 05:53
Kestrel Group Wins Favorable Reinsurance Arbitration Award
Kestrel Group ( ($KG) ) has provided an update. On June 2, 2026, an arbitration...
06-09 05:34
Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors
Kura Oncology reported promising results from the FIT-001 trial combining darlifarnib and adagrasib in KRAS G12C-mutated solid tumors. The combination showed tumor shrinkage in 77% of patients, with ORRs of 67% in PDAC, 50% in NSCLC, and 29% in CRC. Darlifarnib demonstrated consistent activity across tumor types and manageable safety, reinforcing its potential as a precision combination agent. Results will be presented at the 2026 ASCO meeting, w...
05-26 10:02
Kestrel Group Q1 Adj. EPS $(1.34) Down From $(0.14) YoY, Sales $10.193M Up From $841.000K YoY
Kestrel Group (NASDAQ:KG) reported quarterly losses of $(1.34) per share. This is a 857.14 percent decrease over losses of $(0.14) per share from the same period last year. The company reported $10.193 million in sales
05-09 04:19
14.5亿美元！艾伯维锁定一款pan-KRAS抑制剂
（来源：求实药社） 2026年4月28日，临床阶段生物技术公司Kestrel Therapeutics宣布两项重要进展： 其一，公司在研口服小分子pan-KR...
04-29 12:02
Full Transcript: Enphase Energy Q1 2026 Earnings Call
On Tuesday, Enphase Energy (NASDAQ:ENPH) discussed first-quarter financial resu...
04-29 06:09
Navigator to sell eight gas carriers, Unigas JV stake
Navigator Holdings (NVGS) signed a non-binding letter of intent with Bernhard Schulte and Sloman Neptun to sell eight gas carriers and its stake in the Unigas joint venture, which currently commercial...
04-15 14:46
港股早知道 | 创新药板块或迎重大利好？国办公布14条举措！事关健全药品价格形成机制；兖煤澳大利亚拟收购红隼煤矿80%权益
创新药板块或迎重大利好？国办公布14条举措！事关健全药品价格形成机制；兖煤澳大利亚拟最高24亿美元收购红隼煤矿80%权益；锅圈Q1核心经营利润同比增超45%>>
04-15 07:55
